AEHR

⬣ Class Action

Aehr Test Systems, Inc.

Securities Class Action Lawsuit

What Is the Aehr Test Systems, Inc. (AEHR) Class Action Lawsuit About?

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. (“Aehr” or “the Company”) (NASDAQ: AEHR) and certain of its officers.

Class Definition

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Aehr securities between January 9, 2024, and March 24, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case.

What Does the Aehr Test Systems, Inc. Securities Class Action Allege?

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on the Company’s revenue growth; (3) accordingly, the Company’s business and/or financial prospects were overstated; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.

What’s Next?

A class action lawsuit has already been filed. You may review a copy of the Complaint. You may also contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660. If you suffered a loss in Aehr you have until February 3, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff.

How Did Aehr Test Systems, Inc. (AEHR) Stock React to the Disclosures?

Filed Complaint

Review the full class action complaint as filed in court.

View PDF

How Is BG&G Representing Investors in Securities Class Actions?

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”
— Peretz Bronstein, Founding Partner

The deadline for lead plaintiff for this case has passed.

Thank you for your interest.